PL3083557T3 - Sposób otrzymywania 3-podstawionych estrów kwasu (indol-1-ilo)-octowego - Google Patents
Sposób otrzymywania 3-podstawionych estrów kwasu (indol-1-ilo)-octowegoInfo
- Publication number
- PL3083557T3 PL3083557T3 PL14814989T PL14814989T PL3083557T3 PL 3083557 T3 PL3083557 T3 PL 3083557T3 PL 14814989 T PL14814989 T PL 14814989T PL 14814989 T PL14814989 T PL 14814989T PL 3083557 T3 PL3083557 T3 PL 3083557T3
- Authority
- PL
- Poland
- Prior art keywords
- indol
- substituted
- preparation
- acetic acid
- acid esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1322273.2A GB201322273D0 (en) | 2013-12-17 | 2013-12-17 | Process |
| PCT/GB2014/053686 WO2015092372A1 (en) | 2013-12-17 | 2014-12-12 | Process for the preparation of 3-substituted (indol-1-yl)-acetic acid esters |
| EP14814989.1A EP3083557B1 (en) | 2013-12-17 | 2014-12-12 | Process for the preparation of 3-substituted (indol-1-yl)-acetic acid esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3083557T3 true PL3083557T3 (pl) | 2018-05-30 |
Family
ID=50031022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14814989T PL3083557T3 (pl) | 2013-12-17 | 2014-12-12 | Sposób otrzymywania 3-podstawionych estrów kwasu (indol-1-ilo)-octowego |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9828359B2 (pl) |
| EP (1) | EP3083557B1 (pl) |
| JP (1) | JP6312179B2 (pl) |
| DK (1) | DK3083557T3 (pl) |
| ES (1) | ES2660467T3 (pl) |
| GB (1) | GB201322273D0 (pl) |
| HR (1) | HRP20180298T1 (pl) |
| HU (1) | HUE036184T2 (pl) |
| NO (1) | NO3083557T3 (pl) |
| PL (1) | PL3083557T3 (pl) |
| PT (1) | PT3083557T (pl) |
| RU (1) | RU2676332C1 (pl) |
| SI (1) | SI3083557T1 (pl) |
| TR (1) | TR201802657T4 (pl) |
| UA (1) | UA117849C2 (pl) |
| WO (1) | WO2015092372A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| WO2018014869A1 (zh) * | 2016-07-21 | 2018-01-25 | 正大天晴药业集团股份有限公司 | 作为crth2抑制剂的吲哚衍生物 |
| WO2020136093A1 (en) | 2018-12-27 | 2020-07-02 | Chiesi Farmaceutici S.P.A. | Process for preparing spherical agglomerates of timapiprant |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3489767A (en) | 1966-01-12 | 1970-01-13 | Sumitomo Chemical Co | 1-(phenylsulfonyl)-3-indolyl aliphatic acid derivatives |
| US3557142A (en) | 1968-02-20 | 1971-01-19 | Sterling Drug Inc | 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters |
| BE790679A (fr) | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
| GB1407658A (en) | 1973-03-06 | 1975-09-24 | Ici Ltd | Process for the manufacture of indole derivatives |
| GB1460348A (en) | 1974-02-04 | 1977-01-06 | Ici Ltd | Quinazoline derivativesa |
| DK151884C (da) | 1979-03-07 | 1988-06-13 | Pfizer | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf |
| US4363912A (en) | 1980-12-15 | 1982-12-14 | Pfizer Inc. | Indole thromboxane synthetase inhibitors |
| US4966911A (en) | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
| GB8607294D0 (en) | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
| WO1993012786A1 (en) | 1986-07-10 | 1993-07-08 | Howard Harry R Jr | Indolinone derivatives |
| US5236945A (en) | 1990-06-11 | 1993-08-17 | Pfizer Inc. | 1H-indazole-3-acetic acids as aldose reductase inhibitors |
| GB9122590D0 (en) | 1991-10-24 | 1991-12-04 | Lilly Industries Ltd | Pharmaceutical compounds |
| US5612360A (en) | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
| GB9317764D0 (en) | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| US5641800A (en) | 1994-07-21 | 1997-06-24 | Eli Lilly And Company | 1H-indole-1-functional sPLA2 inhibitors |
| IL117208A0 (en) | 1995-02-23 | 1996-06-18 | Nissan Chemical Ind Ltd | Indole type thiazolidines |
| JP3144805B2 (ja) | 1996-06-05 | 2001-03-12 | 株式会社 ビー・エム・エル | ヒトＴｈ２特異的タンパク質及びこれをコードする遺伝子（Ｂ１９）並びにこれに関連する形質転換体、組換えベクター及びモノクローナル抗体 |
| EA200000868A1 (ru) | 1998-02-25 | 2001-04-23 | Дженетикс Инститьют, Инк. | Ингибиторы фосфолипаз |
| US6916841B2 (en) | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| DE69918278T2 (de) | 1998-03-31 | 2005-07-14 | The Institutes for Pharmaceutical Discovery, Inc., Branford | Substituierte indolalkansäure |
| TNSN99224A1 (fr) | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
| ATE315230T1 (de) | 1999-08-23 | 2006-02-15 | Bml Inc | Verfahren zum identifizieren von prostaglandin d2 rezeptor modulatoren |
| US20010044437A1 (en) | 2000-01-14 | 2001-11-22 | Dale Robinson | Methods for reducing uric acid levels |
| WO2001064205A2 (en) | 2000-03-02 | 2001-09-07 | The Institutes For Pharmaceutical Discovery, Llc | Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor |
| JP2001247570A (ja) | 2000-03-08 | 2001-09-11 | Japan Tobacco Inc | インドール酢酸化合物及びその製造方法 |
| US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| JPWO2003097042A1 (ja) | 2002-05-16 | 2005-09-15 | 塩野義製薬株式会社 | Ｐｇｄ２受容体拮抗剤 |
| AU2003231509A1 (en) | 2002-05-16 | 2003-12-02 | Shionogi And Co., Ltd. | Compound exhibiting pgd 2 receptor antagonism |
| TW200307542A (en) * | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
| SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| AU2003297727A1 (en) | 2002-12-10 | 2004-06-30 | Wyeth | Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| EA011087B1 (ru) | 2002-12-20 | 2008-12-30 | Эмджен Инк. | Соединения и фармацевтические композиции для лечения воспалительных заболеваний |
| CA2542716A1 (en) | 2003-10-14 | 2005-05-06 | Oxagen Limited | Compounds having crth2 antagonist activity |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| GB0504150D0 (en) * | 2005-03-01 | 2005-04-06 | Oxagen Ltd | Microcrystalline material |
| GB0505048D0 (en) * | 2005-03-11 | 2005-04-20 | Oxagen Ltd | Compounds with PGD antagonist activity |
| GB0605743D0 (en) | 2006-03-22 | 2006-05-03 | Oxagen Ltd | Salts with CRTH2 antagonist activity |
| SI2046740T1 (sl) | 2006-07-22 | 2012-12-31 | Oxagen Limited | Spojine s crth2 antagonistiäśno aktivnostjo |
| US20110124683A1 (en) | 2007-11-13 | 2011-05-26 | Oxagen Limited | Use of CRTH2 Antagonist Compounds |
| PL2327693T3 (pl) * | 2007-12-14 | 2012-11-30 | Pulmagen Therapeutics Asthma Ltd | Indole i ich zastosowanie terapeutyczne |
| RS53142B (sr) | 2008-01-18 | 2014-06-30 | Atopix Therapeutics Limited | Jedinjenja koja imaju antagonističku aktivnost na crth2 |
| US7750027B2 (en) | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
| EP2265581A1 (en) | 2008-01-22 | 2010-12-29 | Oxagen Limited | Compounds having crth2 antagonist activity |
| WO2009093029A1 (en) * | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
| WO2010142934A1 (en) * | 2009-06-12 | 2010-12-16 | Pulmagen Therapeutics (Asthma) Limited | Indole derivatives as ligands of crth2 receptors |
| WO2011055270A1 (en) * | 2009-11-04 | 2011-05-12 | Wyeth Llc | Indole based receptor crth2 antagonists |
| GB201103837D0 (en) | 2011-03-07 | 2011-04-20 | Oxagen Ltd | Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid |
| GB201121557D0 (en) | 2011-12-15 | 2012-01-25 | Oxagen Ltd | Process |
| GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
-
2013
- 2013-12-17 GB GBGB1322273.2A patent/GB201322273D0/en not_active Ceased
-
2014
- 2014-12-12 HU HUE14814989A patent/HUE036184T2/hu unknown
- 2014-12-12 JP JP2016560049A patent/JP6312179B2/ja not_active Expired - Fee Related
- 2014-12-12 PT PT148149891T patent/PT3083557T/pt unknown
- 2014-12-12 NO NO14814989A patent/NO3083557T3/no unknown
- 2014-12-12 SI SI201430614T patent/SI3083557T1/en unknown
- 2014-12-12 EP EP14814989.1A patent/EP3083557B1/en active Active
- 2014-12-12 RU RU2016125326A patent/RU2676332C1/ru active
- 2014-12-12 US US15/307,998 patent/US9828359B2/en not_active Expired - Fee Related
- 2014-12-12 TR TR2018/02657T patent/TR201802657T4/tr unknown
- 2014-12-12 DK DK14814989.1T patent/DK3083557T3/en active
- 2014-12-12 WO PCT/GB2014/053686 patent/WO2015092372A1/en not_active Ceased
- 2014-12-12 PL PL14814989T patent/PL3083557T3/pl unknown
- 2014-12-12 HR HRP20180298TT patent/HRP20180298T1/hr unknown
- 2014-12-12 ES ES14814989.1T patent/ES2660467T3/es active Active
- 2014-12-12 UA UAA201607416A patent/UA117849C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201322273D0 (en) | 2014-01-29 |
| TR201802657T4 (tr) | 2018-03-21 |
| RU2676332C1 (ru) | 2018-12-28 |
| ES2660467T3 (es) | 2018-03-22 |
| HRP20180298T1 (hr) | 2018-04-06 |
| DK3083557T3 (en) | 2018-03-12 |
| PT3083557T (pt) | 2018-03-05 |
| HUE036184T2 (hu) | 2018-06-28 |
| JP6312179B2 (ja) | 2018-04-18 |
| SI3083557T1 (en) | 2018-04-30 |
| JP2017501222A (ja) | 2017-01-12 |
| EP3083557A1 (en) | 2016-10-26 |
| NO3083557T3 (pl) | 2018-04-28 |
| US20170305879A1 (en) | 2017-10-26 |
| EP3083557B1 (en) | 2017-11-29 |
| US9828359B2 (en) | 2017-11-28 |
| WO2015092372A1 (en) | 2015-06-25 |
| UA117849C2 (uk) | 2018-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181696T1 (hr) | Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline | |
| PL2674413T3 (pl) | Sposób wytwarzania treprostynilu i jego pochodnych | |
| GB2522505B (en) | Process for the Production of Carboxylic Acid Esters | |
| IL235802A0 (en) | A new process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid | |
| IL245474A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| ZA201505457B (en) | Process for the preparation of succinic acid ester | |
| ZA201505352B (en) | Process for the preparation of succinic acid ester | |
| ZA201404246B (en) | Process for the preparation of(5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-1yl)-acetic acid | |
| IL245476A0 (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
| HUE036184T2 (hu) | Eljárás a 3-helyzetben helyettesített (indol-1-il)-ecetsav-észterek elõállítására | |
| PL3077359T3 (pl) | Sposób wytwarzania i wyodrębniania estrów kwasów karboksylowych | |
| LT2931696T (lt) | Nepertraukiamas (s)-2-acetiloksipropiono rūgšties gamybos būdas | |
| ZA201405824B (en) | Process for the preparation of substituted phenylpropanones | |
| IL229326A (en) | Process for making n-iodine-affluent | |
| IL239815A0 (en) | Process for preparing derivatives of 4-methylpent-3-en-1-ol | |
| IL246188B (en) | A process for the preparation of tiacomycin |